Protalix BioTherapeutics, Inc (PLX) Stock Price

2.22 ▼ -0.16 (-6.72%)
Open: 2.345 Vol: 504.23K Day's range: 2.23 - 2.35 Nov 06, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
PLX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 2.24▼ 2.25▼ 2.25▼ 2.34▼ 2.23▼
MA10 2.24▼ 2.26▼ 2.29▼ 2.34▼ 2.09▲
MA20 2.25▼ 2.30▼ 2.32▼ 2.31▼ 1.80▲
MA50 2.27▼ 2.33▼ 2.32▼ 2.11▲ 2.01▲
MA100 2.31▼ 2.33▼ 2.27▼ 1.81▲ 1.63▲
MA200 2.33▼ 2.25▼ 2.33▼ 2.05▲ 1.55▲
  5 mins 30 mins Hourly Daily Weekly
MACD -0.001▼ -0.006▼ -0.014▼ -0.019▼ 0.079▲
RSI 24.448▼ 29.456▼ 33.523▼ 48.090▼ 56.252▲
STOCH 12.963▼ 9.374▼ 5.698▼ 59.638     68.220    
WILL %R -88.889▼ -96.875▼ -97.143▼ -36.508     -35.341    
CCI -213.559▼ -140.980▼ -123.911▼ -15.973     77.842    
Latest Filters Detected On PLX
RSI $PLX RSI(14) Crossed Below 50 Set Alert
MA $PLX Price Crossed Below MA(26) Set Alert
MA $PLX Price Crossed Below MA(13) Set Alert
MA $PLX Price Crossed Below MA(7) Set Alert
CDL $PLX Marubozu Candlestick Pattern Detected Set Alert
Protalix BioTherapeutics, Inc News
Protalix BioTherapeutics to Announce Third Quarter 2025 Financial and Business Results on November 13, 2025
Thursday, November 06, 2025 04:02 AM
Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its ...
What’s in store for gold in 2026?
Wednesday, November 05, 2025 11:26 AM
According to the World Bank, gold prices are expected to rise by 42% in 2025, followed by more moderate gains of 5% in 2026 and 6% in 2027, supported by continued, though slower, central bank buying ...
Chiesi Global Rare Diseases and Protalix BioTherapeutics Seek Re-examination from the EMA for the Negative Opinion for Elfabrio (pegunigalsidase alfa) Alternative Dosing ...
Monday, November 03, 2025 01:40 PM
Every two weeks remains approved as a dosing regimen of Elfabrio in the EU --PARMA, Italy and CARMIEL, Israel, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Chiesi Global Rare Diseases, a business unit of the ...
PLX historical stock data
date open high low close volume
06/11/25 2.345 2.35 2.23 2.22 504,228
05/11/25 2.37 2.395 2.28 2.38 521,730
04/11/25 2.31 2.375 2.26 2.34 383,015
03/11/25 2.38 2.41 2.30 2.39 645,800
31/10/25 2.28 2.40 2.24 2.37 478,100
30/10/25 2.34 2.37 2.25 2.26 449,800
29/10/25 2.30 2.42 2.22 2.37 1,631,900
28/10/25 2.41 2.44 2.28 2.30 409,900
27/10/25 2.43 2.45 2.32 2.38 740,900
24/10/25 2.32 2.41 2.25 2.36 740,700
Quote Details
52wk Low:1.18
52wk High:3.10
Vol:504.23K
Avg Vol(3m):14.2M
1Y Chng:+33.73%
1M Chng:+7.77%
Add to Watch List
More Information
Index NYSE AMEX Composite
Market Cap. 189.76M